Trading Signals: TGTX Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 14, 2022)(TG Therapeutics Inc)
| TGTX latest price $41.5400 (1.64%) ($41.5400 - $41.5400) on Wed. May. 5, 2021. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 3.4% (three month average) | RSI | 39 | Latest Price | $41.5400(1.64%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | TGTX declines -1% a day on average for past five trading days. | Weekly Trend | TGTX declines -0.2% a week on average for past two weeks. | Market Behavior | Value stock rally for large cap. Growth stock sell-off for small cap. | Correlated ETFs | Broad market will support TGTX advance at 0% a week (0% probability) XBI(68%) ARKG(63%) ARKK(59%) IBB(58%) IWO(58%) | Factors Impacting TGTX price | TGTX will decline at least -1.7% in a week (0% probabilities). VIXM(-42%) VXX(-36%) UUP(-18%) UNG(-3%) TLT(-2%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.7% (StdDev 3.4%) | Hourly BBV | -0.6 () | Intraday Trend | 0% | | | |
|
1 - 5 Day Possible Target | $34.98(-15.79%) | Resistance Level | $43.32 | 5 Day Moving Average | $42.69(-2.69%) | 10 Day Moving Average | $42.82(-2.99%) | 20 Day Moving Average | $43.32(-4.11%) | To recent high | -23.3% | To recent low | 3.7% | Market Cap | $5.261b | | | | TG Therapeutics, Inc. is a biopharmaceutical company, which engages in the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its product pipeline includes TG-1101, Ublituximab, and Umbralisib. The company was founded by Michael Sean Weiss and Laurence H. Shaw on May 18, 1993 and is headquartered in New York, NY. |